The policy stream Global Health focuses on the most important challenges of the sector, ranging from health systems building, strengthening and resilience, to health financing and regulation, technological innovation, people-centred health care and the availability of sufficient human resources for health.
In order to fit with the sector's job market, the programme is based on a comparative approach and offers two different tracks:
- The French track, entitled Santé (fr.), takes into account the specificities of the French job market (fr);
- the English track, described below, offers large essential perspectives necessary to evolve within today's dynamic global health policy landscape.
The unique multidisciplinary approach of this policy stream trains students to implement integrative problem solving for complex global and domestic health issues, as well as attain integrative understandings of diseases and conditions that afflict developing and developed countries.
Students take courses that cover essential areas - health policy, health economics and law, biostatistics and epidemiology, humanitarian affairs, innovation and eHealth – providing a comprehensive understanding of a sector marked by its constantly changing nature.
- Health: a Global Perspective
- Biostatistics and Epidemiology
- Global health Law and Regulation
- Global health Economics
- Contemporary health issues and challenges
- Digital Innovation and Solutions in Healthcare Industry
- Humanitarian Affairs and Global Health
Graduates from this policy stream pursue careers in a variety of important positions in the health domain, from hospital sectors, public and private, consulting agencies, health agencies, administrations, industries, or in international organizations specialized in the field of health, as well as other community-based and research/academic institutions across the globe.
Master in Public Policy:
Master in European Affairs:
Henri Bergeon - co-director of LIEPP's "Health Policy" Reasearch Group, scientific coordinator of the Sciences Po Health Studies Chair, and co-director of the "Health" subject at the "Presses" of Sciences Po.
He developed his research activities at CNRS and at Sciences Po on health policies and on the transformation of practices in the medical profession. He studies diverse subjects including illicit drugs, alcohol, obesity, medical research and public health policy by using tools from the sociology of public action and the sociology of organizations. He also focuses on the role of knowledge in professional practice and its affect on the way collective opinions are formed.
Daniel Benamouzig is director of research at the CNRS and co-director of the LIEPP "Health Policy" Research Group. He is also the deputy director of the AVIESAN Alliance Institute for Public Health, in charge of coordinating major public operators in this area.
His research ranges from public health and economic policy to institutional governance. He studied the history of health economics and transformations in the regulation of the sector. He continues to conduct research in the field of economic sociology and political sociology of healthcare and he is particularly interested in institutional changes and the mobilization of knowledge in this field.
Louis-Charles Viossat - Inspector General at the French general inspectorate for social affairs (IGAS).
In his functions, he evaluates policies and legislations on health, life sciences, labor and social security. He also audits public, non-profit and private institutions in these areas. Throughout his distinguished career, he has evolved in both the public and the private sector, at the French and global levels. He has worked for the World Bank, has been the chief of staff ofthe French minister of Health, and the deputy chief of staff to the Prime Minister as well as CEO of ACOSS, French social security's "bank". He has also been French Ambassador in charge of the fight against HIV/AIDS and communicable diseases. In the private sector, he has been working at Eli Lilly as corporate affairs director, Abbott as Government affairs director for Western Europe and Canada, and Abbvie, a world leading biopharmaceutical company as Vice-President for International Government Affairs.